Meunier Carlin & Curfman LLC

"Value Without Compromise"


The $300 billion pharmaceutical industry has grown significantly in the last decade and is expected to rise to $400 billion within three years. Advances in technology, drug development and therapeutics have shaped and improved the lives of billions of people. Our pharmaceutical clients invest much of their capital in drug research and development, and their innovations need experienced attorneys to protect their intellectual property assets.

Our pharmaceutical clients vary from venture-funded startups to large, renowned companies. We have experience in patent drafting and prosecution, licensing, ANDA filings and IPR petitions. Our firm also represents clients internationally, including multiple European and Australian Opposition proceedings as the opponent and patentee in areas related to nutraceuticals.

The firm professionals hold advanced degrees in molecular biology, organic chemistry, immunology and veterinary medicine, and can meet the needs of clients that create a variety of drug formulations. We have practice group members who have worked within the pharmaceutical and biomedical industry, including a cancer researcher. Our professionals’ legal experience in therapeutics, diagnostics, biopharmaceuticals, immunogenetics, infectious disease and drug delivery provide the background to aid our clients in patent protection, counseling and litigation. We offer solid, skilled expertise to clients in the expanding pharmaceutical industry.

Representative Professionals

Eric Andreansky PhD
Janell Cleveland

Chris Curfman PhD
Will Cutchins
Yan Feng PhD
Miles Hall, DVM
Shirlene Jackson-Beckford PhD
Gibson Lanier PhD
Drew Meunier
Rachel Near PhD
Lisa Pavento
Don Prather PhD
AJ Zucchero PhD

"Value Without Compromise"

Contact Information

999 Peachtree Street NE, Suite 1300 Atlanta, Georgia 30309

P: 404-645-7700 | F: 404-645-7707